We return on day 7 if day 5 test is negative. If day 5 test is + then rtw day 10 and 24 hours fever free WITHOUT medications to prevent or reduce fever and all other symptoms are improving.

 

Regina

 

From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of Jennifer Carr
Sent: Tuesday, October 11, 2022 8:20 AM
To: MCOH-EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] Question about COVID-19 return to work policies

 

This is an email from Outside HHC. USE CAUTION opening attachments or links from unknown senders.

Erin,

Our employees return on day #7 no testing. 24 hours fever free WITHOUT medications to prevent or reduce fever and all other symptoms improving.

Jennifer

 

From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of Erin McLaughlin
Sent: Monday, October 10, 2022 2:35 PM
To: MCOH-EH <mcoh-eh@mylist.net>
Subject: [MCOH-EH] Question about COVID-19 return to work policies

 

Hello, 

 

I was wondering if anyone would be comfortable sharing their organization's current policy for returning to work following COVID-19 infection?

We were considering making our policy more stringent in light of the updated CDC guidance. I am curious to know what other policies are out there. 

 

Our current policy is:

Return on day #6 if an antigen test is negative on day #5

OR

Return on day #7 (no testing required)

In both cases the employee must be fever-free x24 hours and free of vomiting/diarrhea x48 hours. 

 

Thank you, 

 

--

Erin McLaughlin, MD, MPH

Nuvance Health 

Occupational Health Medical Director 

914-456-9906

 


WARNING: This email originated from outside of Mon Health. Do not click links or open attachments unless you recognize the sender & are expecting the message.

 

Disclaimer: This e-mail and any attachments are confidential and may be protected by legal privilege and are intended only for the use of the addressee (s) named herein. If you are not the intended recipient, an addressee, or the person responsible for delivering this to an addressee, you are hereby notified that reading, using, copying, or distributing any part of this message is strictly prohibited. If you have received this e-mail in error, please return the e-mail to the sender and promptly delete the copy from your system.

Reminder: This e-mail and any attachments are subject to the current HHC email retention policies. Please save or store appropriately in accordance with policy.


This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.